[go: up one dir, main page]

PE35398A1 - 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas - Google Patents

2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas

Info

Publication number
PE35398A1
PE35398A1 PE1997000019A PE00001997A PE35398A1 PE 35398 A1 PE35398 A1 PE 35398A1 PE 1997000019 A PE1997000019 A PE 1997000019A PE 00001997 A PE00001997 A PE 00001997A PE 35398 A1 PE35398 A1 PE 35398A1
Authority
PE
Peru
Prior art keywords
alkyl
formula
vii
hydrogen
compound
Prior art date
Application number
PE1997000019A
Other languages
English (en)
Inventor
Dieter Habich
Andreas Stolle
Hein-Peter Kroll
Rainer Endermann
Stephan Bartel
Walter Guarnieri
Bernd Riedl
Martin Ruppelt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE35398A1 publication Critical patent/PE35398A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE REFIEREN A ANTIBACTERIANOS DE FORMULA (I), EN DONDE: "A" ES OXIGENO O AZUFRE; "D" ES HIDROGENO, ALQUILO O ALQUENILO C1-C9 (OPCIONALMENTE SUSTITUIDOS POR CIANO O HIDROXILO), -(CO)a-NR2R3, -(CT)d-NR10R11, -(CO)e-NR12-CO-NR13R14 o -CO-R20, ENTRE OTROS, EN DONDE: "T" ES OXIGENO O AZUFRE; a, d Y e SON 0 o 1; R2, R3, R10, R11, R12, R13 Y R14 SON H o ALQUILO C1-C5, ENTRE OTROS; R20 ES ARILO C6-C10 OPCIONALMENTE SUSTITUIDO POR HALOGENO; "E" Y "L" PREFERENTEMENTE SON HIDROGENO; R1 ES AZIDO, HIDROXILO, -OR21, -O-SO2R22 o -NR23R24, EN DONDE: R21 ES ACILO C1-C6 o UN GRUPO PROTECTOR OH; R22 ES ALQUILO C1-C5, FENILO o TOLILO; R23 Y R24 SON HIDROGENO, ALCOXI C1-C6 o -CT`-R25, ENTRE OTROS, EN DONDE: T' ES COMO "T"; R25 ES CICLOALQUILO C3-C6, ALQUILO C1-C6, TIOALQUILO C1-C5 o ACILO C1-C5, ENTRE OTROS. TAMBIEN SE REFIERE A LOS COMPUESTOS INTERMEDIOS DE FORMULA (VII), A LOS N-1-OXIDOS DEL COMPUESTO (VII) Y AL COMPUESTO DE FORMULA (IV). ADEMAS SE REFIERE A LOS PROCEDIMIENTOS DE PREPARACION DE LOS COMPUESTOS DE FORMULA (I), QUE COMPRENDE: a) TRANSFORMAR LOS N-1-OXIDOS DEL COMPUESTO DE FORMULA (VII) MEDIANTE REACCION CON Ac2O o p-TsCl/CO3K2 EN DISOLVENTES INERTES, o b) TRANSFORMAR (IV) MEDIANTE REACCION CON ALQUIL-LITIO EN ETERES Y BUTIRATO DE R-GLICIDILO, Y OTROS PROCESOS PARA OBTENER LOS SUSTITUYENTES EN R1
PE1997000019A 1996-01-16 1997-01-14 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas PE35398A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19601265A DE19601265A1 (de) 1996-01-16 1996-01-16 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone

Publications (1)

Publication Number Publication Date
PE35398A1 true PE35398A1 (es) 1998-08-29

Family

ID=7782816

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000019A PE35398A1 (es) 1996-01-16 1997-01-14 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas

Country Status (28)

Country Link
US (1) US5861413A (es)
EP (1) EP0785197A3 (es)
JP (1) JPH09194478A (es)
KR (1) KR970059174A (es)
AR (1) AR005458A1 (es)
AU (1) AU711924B2 (es)
BG (1) BG62257B1 (es)
BR (1) BR9700688A (es)
CA (1) CA2194945A1 (es)
CO (1) CO4520188A1 (es)
CZ (1) CZ12897A3 (es)
DE (1) DE19601265A1 (es)
EE (1) EE9700019A (es)
HN (1) HN1996000124A (es)
HR (1) HRP960614A2 (es)
HU (1) HUP9700126A3 (es)
IL (1) IL119994A0 (es)
NO (1) NO970174L (es)
NZ (1) NZ314057A (es)
PE (1) PE35398A1 (es)
PL (1) PL317930A1 (es)
SG (1) SG46764A1 (es)
SK (1) SK5897A3 (es)
SV (1) SV1997000002A (es)
TN (1) TNSN97009A1 (es)
TR (1) TR199601002A1 (es)
YU (1) YU1097A (es)
ZA (1) ZA97302B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19802239A1 (de) * 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
CN1288462A (zh) 1998-01-23 2001-03-21 法玛西雅厄普约翰美国公司 噁唑烷酮组合库、组合物和制备方法
KR20010052615A (ko) * 1998-06-05 2001-06-25 다비드 에 질레스 옥사졸리디논 유도체, 이것의 제조 방법 및 이것을함유하는 약학 조성물
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6544991B2 (en) 2000-06-30 2003-04-08 Pharmacia & Upjohn Company Compositions and methods for treating bacterial infections
JP2004518677A (ja) * 2000-12-21 2004-06-24 ファルマシア・アンド・アップジョン・カンパニー 抗菌性キノロン誘導体および細菌感染を治療するためのその使用
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
DE60304360T2 (de) * 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
WO2004026848A1 (en) * 2002-09-20 2004-04-01 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
AR042086A1 (es) * 2002-11-21 2005-06-08 Upjohn Co N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
ATE411312T1 (de) * 2002-12-04 2008-10-15 Glaxo Group Ltd Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
JP2006516989A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤として使用するための二環式環によりn−置換されたオキサゾリジノン誘導体
BRPI0407252A (pt) * 2003-02-07 2006-01-31 Warner Lambert Co Agentes antibacterianos.
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US20070155714A1 (en) 2003-04-30 2007-07-05 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
JP2007516263A (ja) 2003-12-18 2007-06-21 モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー オキサゾリジノン−キノロンハイブリッド抗生物質
US7494578B2 (en) * 2004-03-01 2009-02-24 Atotech Deutschland Gmbh Iron-phosphorus electroplating bath and method
AU2005270951A1 (en) * 2004-08-06 2006-02-16 Pharmacia & Upjohn Company Llc Oxazolidinones containing oxindoles as antibacterial agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
TW200831517A (en) * 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
RU2501799C2 (ru) * 2008-02-22 2013-12-20 Актелион Фармасьютикалз Лтд Поизводные оксазолидинона
EP3177593A1 (en) * 2014-08-06 2017-06-14 Novartis AG Quinolone derivatives as antibacterials
KR20220055171A (ko) * 2020-10-26 2022-05-03 주식회사 아이비스바이오 포말리도마이드로부터 3,6'-디티오포말리도마이드를 선택적으로 합성하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4801600A (en) 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4942183A (en) * 1987-10-16 1990-07-17 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
EP0609905B1 (en) 1988-09-15 2001-06-06 PHARMACIA & UPJOHN COMPANY 3-(Nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones
JP2669579B2 (ja) * 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
DE4332384A1 (de) 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
TW286317B (es) * 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone

Also Published As

Publication number Publication date
ZA97302B (en) 1997-07-17
TNSN97009A1 (fr) 2005-03-15
CA2194945A1 (en) 1997-07-17
HUP9700126A3 (en) 1999-05-28
KR970059174A (ko) 1997-08-12
TR199601002A1 (tr) 1997-08-21
NO970174D0 (no) 1997-01-15
SK5897A3 (en) 1997-09-10
HN1996000124A (es) 1997-06-18
BG62257B1 (bg) 1999-06-30
CO4520188A1 (es) 1997-10-15
NO970174L (no) 1997-07-17
US5861413A (en) 1999-01-19
DE19601265A1 (de) 1997-07-17
HRP960614A2 (en) 1998-02-28
AU711924B2 (en) 1999-10-21
HU9700126D0 (en) 1997-02-28
AU1009797A (en) 1997-07-24
EP0785197A2 (de) 1997-07-23
MX9700419A (es) 1997-07-31
IL119994A0 (en) 1997-04-15
YU1097A (sh) 1999-12-27
NZ314057A (en) 1998-11-25
SG46764A1 (en) 1998-02-20
HUP9700126A2 (hu) 1998-12-28
BR9700688A (pt) 1998-09-01
EP0785197A3 (de) 1999-02-10
PL317930A1 (en) 1997-07-21
JPH09194478A (ja) 1997-07-29
AR005458A1 (es) 1999-06-23
BG101131A (en) 1998-04-30
EE9700019A (et) 1997-08-15
SV1997000002A (es) 1997-08-29
CZ12897A3 (en) 1997-08-13

Similar Documents

Publication Publication Date Title
PE35398A1 (es) 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas
PE51097A1 (es) Nuevos taxoides, su preparacion y composiciones farmaceuticas que los contienen
ES8604487A1 (es) Un metodo para preparar derivados de alcanoles aromaticos policiclicos
DK0630226T3 (da) Farvning af keratinfibre med endoliner under metalkatalyse
ATE198216T1 (de) Härtbare organopolysiloxanmassen
GB1484122A (en) Glass fibre-reinforced polycarbonates with mechanical properties
KR910021460A (ko) 트리아릴 트리아진 자외선 흡수제, 그의 제조방법 및 그를 포함하는 중합체 안정화 조성물
ES8405398A1 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
DE3481514D1 (de) Neue fructosyltsansferase und verfahren zur herstellung von fructosyl-disacchariden, sowie eine neue halosaccharose.
JPS55130844A (en) Coating agent for light communicating glass fiber
AU679947B2 (en) Method for preparing taxane derivatives
DE3064239D1 (en) Stabilized peroxygen compounds particles, process of preparing them and composition containing them
GR880100208A (en) Preparation method of new aminotetrahydro-5,6,7,8,naphtho (2,3b) furane
AU4761693A (en) Benzopyran and benzoxazine derivatives
PT73338B (en) 3,1-benzoxazin-2-one ihre herstellung und verwendung
IE821260L (en) Anthracycline derivatives
DE3484426D1 (en) Poly(arylenether).
HUT55337A (en) New fluoro-naphtacene-dions, theyr glycozylized derivatives and process for producing them
AU2088388A (en) Process for manufacturing 2,5-diamino-6-nitro-pyridine derivatives, their use in hair dyes, and new 2,5-diamino-6-nitro-pyridine derivatives
HUT43552A (en) Process for preparing novel 1,1,2,2-tetramethyl-1,2-bis(2-fluor-4-hydroxyphenyl)-ethane derivatives
ES8203877A1 (es) Procedimiento de obtencion de nuevos aminoderivados en posi-cion 1, del 1-(3',4'-metilendioxifenil)propan-2-ol
HU9500823D0 (en) Polyiodine compounds, process for producing them, and diagnostical compositions containing them
ES512705A0 (es) Procedimiento para preparar derivados de indol o de indolina.
ATE38659T1 (de) Verfahren zur herstellung von trifluorethoxyoder trifluorethylthiobenzolen.
TW372963B (en) Substituted cycloalkylamino and cycloalkoxy heterocycles, processes for preparing them and their use as pesticides and fungicides

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed